rs372708613
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001166108.2(PALLD):c.2749G>A(p.Glu917Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001166108.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251226Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135754
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1460976Hom.: 0 Cov.: 29 AF XY: 0.0000385 AC XY: 28AN XY: 726892
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1237G>A (p.E413K) alteration is located in exon 8 (coding exon 7) of the PALLD gene. This alteration results from a G to A substitution at nucleotide position 1237, causing the glutamic acid (E) at amino acid position 413 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Pancreatic adenocarcinoma Uncertain:1
This variant has not been reported in the literature in individuals affected with PALLD-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 567473). This variant is present in population databases (rs372708613, gnomAD 0.02%). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 413 of the PALLD protein (p.Glu413Lys). -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.E900K variant (also known as c.2698G>A), located in coding exon 15 of the PALLD gene, results from a G to A substitution at nucleotide position 2698. The glutamic acid at codon 900 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
PALLD-related disorder Uncertain:1
The PALLD c.2698G>A variant is predicted to result in the amino acid substitution p.Glu900Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.024% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-169837077-G-A) and has been interpreted in ClinVar as uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/567473). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at